Purchase Order 75N95019P00477

The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation on September 21, 2022, for $57,524.81 under a firm fixed-price arrangement. Performance is located in Carlsbad, California. The order was issued in response to a solicitation posted September 7, 2022, with a due date of September 13, 2022. Ultimate completion is scheduled for October 30, 2022. No set-aside was applied. The award covers commercial scientific equipment, reagents, consumables, or related...

<p>The National Institute on Drug Abuse awarded a purchase order to Illumina, Inc. valued at $132,088.15 on December 17, 2024, for the FY26 UDO Initiative under firm fixed-price terms. Place of performance is Rockville, Maryland. The ultimate completion date is December 16, 2025. No set-aside was used. The source does not specify the items or services being procured under this order.</p>

<p>The National Institute on Drug Abuse issued a purchase order to North David K for $14,400.00 on June 14, 2022, for Institutional Animal Care and Use Committee (IACUC) support services. Work is performed in Indian Head, Maryland. The order carries a firm fixed price and an ultimate completion date of June 13, 2025. This purchase order funded the FY26 UDO Initiative and used no set-aside category.</p>

<p>The National Institute on Drug Abuse issued a purchase order to Labcorp Early Development Laboratories Inc. valued at $108,254.16 on July 1, 2023, for completion of pharmacokinetics for the MAD portion of the RR-HNK Phase 1 study under the FY26 UDO initiative. Work is performed in Madison, Wisconsin. The order carries a firm fixed price structure and was not set-aside. Ultimate completion date was June 30, 2025.</p>

<p>The National Institute on Drug Abuse issued a purchase order to Cynthia M Fioriti on March 8, 2022, with a ceiling value of $33,380.00 under the FY26 UDO Initiative. Performance takes place in Washington, DC. The order carries firm fixed price terms and originated from a pre-solicitation opportunity posted December 9, 2021. The ultimate completion date is March 13, 2025.</p>

The National Institute on Drug Abuse issued a purchase order to Aurora Scientific Inc. for $28,701.56 on August 16, 2021, to procure a 1300A Whole Animal System. The order is firm fixed price with no set-aside. Place of performance is 2323 Riverside Drive, Ottawa, Ontario, Canada. The ultimate completion date is October 29, 2021. This purchase order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in...

<p>The National Institute on Drug Abuse awarded a purchase order to Single Cell Discoveries B.V. for single cell RNA sequencing (Sort-Seq) services valued at $30,816.74 on June 28, 2022. Work is performed in the Netherlands. The order was completed on June 27, 2023. This was part of the FY26 UDO Initiative and carries no set-aside.</p>

This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $91,545.00 firm fixed-price purchase order is for the delivery of assorted cell consumables. The contract has no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, has...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,656.84 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation. The contract is to provide Lindsay Kryszak with a custom SimplePlex cartridge kit for 32 samples to support protein analysis. Performance will occur in Baltimore, Maryland over a one year period from December 2023 through December 2024. No subcontractors or set aside designations...

The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $83,907.10 firm-fixed-price purchase order to Biotage, LLC for the supply of a Biotage V-10 Touch System (Evaporator). This equipment will support NIDA's Automated Synthesis Platform for Innovative Research and Execution (ASPIRE) initiative, enabling rapid drying of organic and aqueous samples generated through chemistry workflows. The purchase order was awarded on...